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Abstract
Background: Nausea is a common symptom in youth with chronic abdominal pain. The aims of the current study
were to assess: 1) the frequency of nausea in patients with functional dyspepsia (FD) and irritable bowel syndrome
(IBS), respectively, as defined by Rome IV criteria; and, 2) relationships between nausea and mucosal inflammation
as defined by antral and duodenal eosinophil and mast cell densities. A secondary aim was to assess relationships
between nausea and other gastrointestinal symptoms, non-gastrointestinal somatic symptoms, and psychological
dysfunction.
Methods: Records from patients with pain associated functional gastrointestinal disorders were retrospectively
reviewed for gastrointestinal and somatic symptoms and anxiety, depression, and somatizations scores as assessed
by the Behavior Assessment System for Children (BASC-2). In addition, previous gastric and mucosal biopsies were
assessed for mast cell and eosinophil densities, respectively.
Results: 250 patients, ages 8 to 17 years, were assessed. Nausea was reported by 78% and was equally prevalent in
those with FD alone, those with IBS alone, and those with both FD and IBS. Nausea was associated with increased
mean (21.4 vs. 17.5) and peak (26.2 vs. 22.9) duodenal mast cell densities as compared those without nausea.
Nausea was also associated with a wide variety of individual gastrointestinal symptoms, as well as headaches,
fatigue, and dizziness. Lastly, nausea was associated with elevated self-report scores for anxiety (55.2 vs. 50.0),
depression (50.2 vs. 46.1), and somatization (70.3 vs. 61.8).
Conclusions: Nausea is common in children and adolescents with pain-associated FGIDs as defined by Rome IV
and is not unique to either FD or IBS. Nausea is associated with increased mucosal mast cell density, nongastrointestinal somatic symptoms, and psychologic dysfunction.
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Background
Chronic nausea is common in children, reported by
15.9% in a community sample [1]. For children who fulfill Rome III criteria for a pain-associated functional
gastrointestinal disorder (FGID), the prevalence rate is
even higher (36%) [1]. This makes sense, as nausea tends
to be associated with other gastrointestinal symptoms,
including worse abdominal pain [2]. In youth with functional abdominal pain, co-morbid nausea has been associated with more somatic complaints, greater psychological
dysfunction, increased disability, and poorer prognosis,
making this an important symptom to understand in its
own right [2].
The observed relationships between abdominal pain
and nausea would suggest at least some shared pathophysiology. One possible mechanism would be mucosal
inflammation (e.g. mast cells, eosinophils) which has
been implicated in functional dyspepsia (FD) and irritable bowel syndrome (IBS) but unstudied in relation to
nausea. Mast cells have been extensively evaluated in
adults with IBS. Results have demonstrated increased
mast cell density in the colon, ileum, and duodenum
with increased mast cell degranulation [3–6]. Further,
the density of mast cells in close proximity to neurons
correlates with pain frequency and intensity in adults
with IBS [5]. Mast cells and eosinophils also have been
implicated in FD [7]. A recent systematic review and
meta-analysis of 37 studies concluded that FD is associated with increases in both mast cells and eosinophils in
the antrum and duodenum [8]. Increased eosinophil and
mast cell degranulation has been demonstrated in both
adults and children with FD, further implicating these
two cells in this condition [9–12].
Mast cells, in particular, would have the potential to
increase nausea in patients with FD. Nausea is a common symptom in patients with mastocytosis or mast cell
activation syndrome as mast cells release cytokines
which can lead to nausea [13–15]. In patients with eosinophilic esophagitis, higher tryptase levels are associated with increased nausea frequency [16]. Furthermore,
in youth with FD, increased mast cell density is associated with slower gastric emptying and increased gastric
dysrhythmia [11]. Gastric dysrhythmia has been associated with nausea [17, 18].
Previous studies of nausea have assessed patients with
FGIDs associated with abdominal pain as defined by
Rome III criteria. The criteria have undergone some significant revisions in the most recent Rome IV criteria,
particularly in how FD and IBS are defined. Previously,
under Rome III, FD was defined as upper abdominal
pain or discomfort unrelated to stools [19]. Under Rome
IV, FD is defined by the presence of: 1) epigastric abdominal pain unrelated to stools; 2) early satiety; and/or,
3) postprandial fullness [20]. IBS is defined by the
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presence of pain related to a change in: 1) stool frequency; 2) stool consistency; or, 3) pain with stooling.
Previously, Rome III criteria required two of these symptoms to be present, while Rome IV criteria only requires
one of these symptoms to be present [19, 20]. Changes
in criteria may be important in assessing associations between nausea and FGIDs. For example, Kovacic and colleagues evaluated children with abdominal pain and
nausea to determine whether symptom profiles fulfilled
Rome III FD criteria, and found that 87% met adult FD
criteria while only 29% met pediatric criteria [21].. This
is relevant because the Rome III adult FD criteria are
akin to the Rome IV pediatric FD criteria. Thus, it is
likely that the diagnosis rate and group composition of
patients included in studies using Rome III versus Rome
IV pediatric criteria is quite different and, consequently,
earlier findings regarding the relationship between abdominal pain and nausea based on Rome III classification many not be generalizable moving forward.
The major aims of the current study were to assess: 1)
the frequency of nausea in patients with FD and IBS, respectively, as defined by Rome IV criteria; and, 2) relationships between nausea and mucosal inflammation as
defined by antral and duodenal eosinophil and mast cell
densities. A secondary aim was to assess relationships
between nausea and other gastrointestinal symptoms,
non-gastrointestinal somatic symptoms, and psychological dysfunction. Understanding the relationship between nausea, the new Rome IV diagnostic criteria, and
inflammation will be important in order to determine if
Rome IV provides cleaner diagnostic categories as related to nausea and to evaluate whether nausea should
be viewed as a treatment target separate from abdominal
pain or if the two should be viewed as co-morbid conditions with shared inflammatory pathophysiology.

Methods
The study retrospectively evaluated 250 consecutive patients diagnosed with an abdominal pain-associated
FGID by a single board-certified pediatric gastroenterologist in an abdominal pain clinic at Children’s Mercy
Kansas City. The study was approved by the Institutional
Review Board Children’s Mercy Kansas City and has
been performed in accordance with the ethical standards
as laid down in the 1964 Declaration of Helsinki and its
later amendments. Patients ranged in age from 8 to 17
years and all reported abdominal pain which occurred at
least weekly for a minimum of 8 weeks. All patients
completed a standard questionnaire as part of routine
clinical evaluation. The questionnaire contained specific
questions regarding symptoms required to classify patients according to Rome IV criteria, as well as other
gastrointestinal symptoms and non-gastrointestinal somatic symptoms.
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As part of routine clinical care, patients completed the
Behavior Assessment System for Children – Second
Edition (BASC-2) to assess for symptoms of anxiety, depression, and somatization [22]. The BASC-2 has demonstrated criterion-related and construct validity, has
good internal consistency for most individual subscales,
and is widely used in both clinical and research settings
[22]. Standardized T scores for the self-report depression, anxiety, and somatization subscales were used for
the current study. Self-report BASC data was available
for 234 patients (94%).
A total of 208 patients (83%) had undergone an esophagogastroduodenoscopy with biopsies. All had failed
to respond to acid reduction therapy. A minimum of 2
biopsies had been obtained from each of the antrum and
the duodenum. All patients were negative for nodularity,
erosions, ulcers, and Helicobacter pylori. Antral and
duodenal biopsy specimens were assessed for eosinophil
and mast cell densities, respectively. Eosinophils were
assessed utilizing hematoxylin and eosin (H&E) stained
slides obtained as part of routine care. An immunohistochemical stain for tryptase was utilized to determine
mast cell densities. A mouse monoclonal antibody, antihuman mast cell tryptase, from Dako (clone AA1) was
used at a dilution of 1:2000 on the Bond automated
immunostainer following the routine immunohistochemistry protocol.
To determine eosinophil and mast cell densities, sections were initially scanned at a low magnification (10X)
to determine areas of subjective maximal density. Using
an Olympus CH30 microscope with a combination of
40x objective and 10x eyepiece (400X), lamina propria
cells were counted in five consecutive high-power fields
(hpf). Only eosinophils demonstrating a nucleus were
enumerated. Mast cells of both spindled and epithelioid
forms showing a nucleus were enumerated. Peak and
mean cell densities were determined for the eosinophils
and mast cells, respectively, in both the antrum and the
duodenum. All cell counts were performed by a single
observer (MS).
Statistical analysis

SPSS version 23 (SPSS INc., Chicago, IL) was used to
perform statistical analysis. The frequencies of a positive
report of nausea were compared between patients meeting criteria for FD only, those meeting criteria for IBS
only, and those meeting criteria for both FD and IBS
(FD/IBS overlap) by chi square analysis. Mean and peak
eosinophil and mast cell densities, as well as anxiety, depression, and somatization T scores, respectively, were
compared for patients reporting nausea versus those
who did not. For continuous variables, normality was
assessed by utilizing Shapiro-Wilk. For parameters with
normal distributions, significance was assessed by the
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student’s t test. For parameters with non-normal distributions, significance was assessed by Mann-Whitney U.
In addition, effects sizes were determined utilizing
cohen’s d for all parameters with differences determined
to be statistically significant. Frequencies of specific
gastrointestinal and non-gastrointestinal somatic symptoms also were compared between these groups by chi
square analysis. A p value <.05 was considered statistically significant for all analyses.

Results
A total of 250 consecutive patients presenting with
chronic abdominal pain were evaluated. Patients ranged
in age from 8 to 17 years (mean 13.2 ± 2.6 years) and
73% were female. Patient reported pain duration ranged
from 2 to 190 months (mean 29.9 ± 38.0 months). The
pain was reported as daily by 76%, several times per
week by 17%, and weekly by 8%. Rome IV criteria for FD
were fulfilled by 86%, IBS criteria were fulfilled by 58%,
and both FD and IBS criteria were fulfilled by 50%. Frequencies for other gastrointestinal symptoms are shown
in Table 1.
Nausea was reported by 78% of patients. Nausea was
seen in similar proportions of FD and IBS patients being
reported by 81% of patients fulfilling FD criteria only,
75% of patients fulfilling IBS criteria, and 80% of patients
fulfilling both FD and IBS criteria (p = 0.814). Of those
patients reporting nausea, it was daily in 37%, several
times per week in 37%, weekly in 9%, and less than
weekly in 17%. Nausea increased with meals on at least
some occasions in 27.7% of patients. Vomiting was reported by 33.6% of patients.
Antral and duodenal mucosal specimens were available for 208 patients. For ease of interpretation, we
present mean and peak duodenal mast cell densities, p
values for t tests, and standard error of differences for
patients with and without nausea in Table 2. Nausea was
associated with increased duodenal mast cell density.
There were no group differences for antral mast cell
Table 1 Frequencies of specific gastrointestinal symptoms in
patients with abdominal pain-associated functional
gastrointestinal disorders (N = 250)
Symptom

% of Patients

Pain with eating

73

Early satiety

70

Waking at night with pain

56

Postprandial bloating

51

Heartburn

38

Vomiting

26

Diarrhea

22

Constipation

15
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Table 2 Mucosal eosinophil and mast cell densities in patients
with and without nausea

Table 4 Self-report BASC subscales in patients with and without
nausea

Nausea positive Nausea negative p value
(N = 169)
(N = 39)

Variable

Mean antral eosinophils

10.5 ± 9.2

10.0 ± 7.0

NS

Anxiety

55.2 ± 11.4

50.0 ± 10.0

.002

Peak antral eosinophils

15.0 ± 12.0

15.1 ± 9.6

NS

Depression

50.2 ± 9.7

46.1 ± 8.0

.006

Mean duodenal eosinophils 21.1 ± 11.9

20.9 ± 8.7

NS

Somatization

70.3 ± 10.6

61.8 ± 10.1

<.001

Peak duodenal eosinophils

28.2 ± 12.0

NS

Variable

28.1 ± 14.7

Mean antral mast cells

15.6 ± 5.6

15.1 ± 6.1

NS

Peak antral mast cells

20.2 ± 7.3

19.9 ± 8.2

NS

Mean duodenal mast cells

21.4 ± 17.1

17.5 ± 6.3

.02

Peak duodenal mast cells

26.2 ± 9.7

22.9 ± 7.4

.02

densities or eosinophil densities in either the antrum or
duodenum. Antral mean and peak mast cell densities
were normally distributed while all other densities were
not. Non-parametric methods confirmed significance for
both mean (p = 0.034) and peak (p = 0.029) duodenal
mast cell densities. Effect sizes were small to medium
for both mean (cohen’s d = 0.303) and peak (cohen’s d =
0.383) duodenal mast cell densities.
The frequencies for other gastrointestinal and nongastrointestinal somatic symptoms in patients with and
without nausea are shown in Table 3. Mean self-report
scores, standard error of differences, and effect sizes for
anxiety, depression and somatization in patients with
and without nausea are shown in Table 4, along with p
values for t tests. All 3 of these subscales were elevated
in patients with nausea relative to those patients without
nausea. Somatization scores were normally distributed
while those for anxiety and depression were not. Nonparametric methods confirmed significance for both
anxiety (p = 0.004) and depression (p = 0.001) scores. Effect sizes were medium for anxiety (cohen’s d = 0.485)

Table 3 Frequencies of gastrointestinal and non-GI somatic
symptoms in patients with and without nausea
Symptom

Nausea positive Nausea negative p value
(N = 195)
(N = 55)

Pain with eating

73.2

73.1

NS

Early satiety

73.1

57.6

.03

Postprandial bloating

56.6

30.8

.001

Vomiting

32.8

0

<.001

Heartburn

42.9

17.3

.001

Change in stool frequency 23.2

5.8

.003

Change in stool form

30.3

15.4

.03

Pain relief with stool

40.4

48.1

NS

Headache

74.3

52.0

.003

Fatigue

56.3

34.0

.006

Dizziness

60.0

21.7

<.001

Nausea positive
(N = 184)

Nausea negative
(N = 50)

P value

and depression (cohen’s d = 0.461) and large for
somatization (cohen’s d = 0.821).

Discussion
Nausea is a very common symptom in children and adolescents fulfilling Rome IV criteria for FD and/or IBS, respectively. Nausea was equally common in the two
conditions being present in approximately 80% of each
in the current study. The frequency is similar to the 87%
previously reported in youth fulfilling Rome III adult FD
criteria, which are akin the Rome IV pediatric FD criteria [21]. Nausea was associated with a number of specific gastrointestinal symptoms. These include dyspeptic
(early satiety and postprandial bloating) and IBS (change
in stool form and frequency) symptoms, as well as symptoms not specific to either condition (vomiting and
heartburn). This further demonstrates that nausea is not
unique to any specific abdominal pain-associated FGID.
In the current study, we have demonstrated an increase in duodenal mast cells in FD patients with nausea,
beyond what would have presumably occurred with the
abdominal pain associated functional gastrointestinal
diagnosis alone. Whether the observed differences are
clinically significant is not clear. This association with
nausea appears unique to mast cells, as eosinophil density did not differ between those with and without nausea
in the current study. This indicates that relationships between inflammatory cells and nausea are unique and
separate from FGID more generally, as previous studies
in children and adults with FD have demonstrated increased duodenal eosinophil density [8]. While we are
only able to assess an association in the current study, it
is possible that mast cell activation could induce nausea
by direct or indirect effects of released mediators on
central nervous system functioning or by altering gastric
motor function. We have previously found an association between increased mucosal mast cell density and
gastric dysrhythmia and slower gastric emptying [11].
Jericho and colleagues have reported an association between nausea and slow gastric emptying in children and
adolescents [23]. Likewise, nausea has been associated
with gastric dysrhythmia [17, 18]. As nausea can be a
distressing symptom, it is also possible that nausea induced a physical stress response with subsequent mast
cell recruitment. Alternatively, the autonomic nervous
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system may play a role. Tarbell and colleagues previously
reported an association between chronic nausea and autonomic dysfunction [24]. Altered autonomic function has
been reported in children with both IBS and FD [25, 26].
In the current study, nausea was associated with
higher self-reported scores for anxiety, depression, and
somatization. Previous studies also have found an association for nausea (alone or in combination with abdominal pain) with anxiety, depression, and somatization [2,
24, 27]. In addition, nausea has been associated with
poor school and social functioning [21]. In the current
study, nausea also was associated with increased frequencies of specific non-gastrointestinal somatic complaints, including headache, fatigue, and dizziness.
Associations with dizziness and fatigue have previously
been reported with nausea [27]. The association of nausea with these somatic symptoms suggests a common
pathophysiologic process. The possibility of mast cell activation was raised above. We have previously demonstrated an association between mast cell density and
somatization as well as anxiety and depression in youth
with FD [28]. Anxiety and depression have been associated
with mast cell density and degranulation in adults with FD
[9]. Another proposed mechanism is autonomic dysfunction, which has been associated with anxiety in children
with nausea and those with abdominal pain [24, 25].
A strength of the current study is the systematic collection of symptoms and the availability of mucosal
specimens for analysis in a large population of patients
with abdominal pain. A limitation of the current study is
that 17% of the patients did not have biopsies to be evaluated. This could have introduced some possible bias, as
endoscopy is not routinely performed in patients with
IBS alone and, thus, biopsies in the locations of interest
were more likely to have been obtained in patients with
FD (with or without IBS). As nausea was equally prevalent in FD and IBS in our patient group, this oversampling of patients with FD is unlikely to have had a
significant impact on our results and, at a minimum, the
current study would at least provide information on
nausea’s association with mucosal inflammation relevant
to the large group of patients with FD. Another limitation of the current study is that cell counts represent
only a gross measure of inflammation; as such, they do
not allow an assessment of general activation or an assessment of specific mediator concentrations to determine which mediators, if any, are contributing to the
symptom of nausea. Understanding specific mediator
contributions might indicate specific therapeutic targets.
It should be emphasized that this is an observational,
cross-sectional study and therefore, cause-and-effect
cannot be imputed. Lastly, as validated pediatric measures of nausea severity were not available at the time of
data collection, we were unable to assess relationships
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for varying degrees of nausea severity. A measure is
now available and should be incorporated into future
studies [29].

Conclusions
Nausea is common in children and adolescents with
pain-associated FGIDs as defined by Rome IV and is not
unique to either FD or IBS. Nausea is associated with increased mucosal mast cell density, non-gastrointestinal
somatic symptoms, and psychologic dysfunction. Because of the distressing nature of nausea, and its negative associations with school and social functioning, it
represents a treatment target of importance in its own
right. Prospective studies are needed to determine what
is driving the association between nausea, mast cells,
and psychological dysfunction, specifically to assess
whether there is a cause-and-effect relationship. Future
studies should evaluate specific mast cell mediators in
relation to nausea and evaluate the efficacy of medications directed at mast cell stabilization or antagonism of
specific mast cell mediators in the treatment of nausea.
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